Status:
COMPLETED
An Investigational Scan (Ga-68 PSMA-11 PET/CT) for the Detection of Therapy Response in Patients With Metastatic Adenoid Cystic Carcinoma
Lead Sponsor:
Mayo Clinic
Conditions:
Metastatic Adenoid Cystic Carcinoma
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This phase II trial tests whether gallium-68 (Ga-68) prostate specific membrane antigen (PSMA)-11 positron emission tomography (PET)/computed tomography (CT) imaging is useful for detecting therapy re...
Detailed Description
PRIMARY OBJECTIVES: I. Evaluate the feasibility of serial Ga-68 PSMA PET/CT for response assessment in metastatic adenoid cystic carcinoma. II. Assess the correlation of PSMA PET/CT response assessm...
Eligibility Criteria
Inclusion
- ≥ 18 years of age
- Diagnosis of metastatic adenoid cystic carcinoma
- Enrolled in protocol MC200708
- Ability to tolerate a Ga68 PSMA PET/CT imaging study
- Willingness to return for a second PSMA PET/CT scan in approximately 12-20 weeks from the baseline PET/CT
- Ability to give appropriate consent or have an appropriate representative available to do so
Exclusion
- Unable to undergo PET/CT scan
- Not a participant in MC200708
- \< 18 years of age
- Persons who are pregnant or nursing
- Persons unable to consent to the study
Key Trial Info
Start Date :
August 12 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 12 2025
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT06521775
Start Date
August 12 2024
End Date
August 12 2025
Last Update
September 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905